Business Context and Reporting Period
This Form 6-K filing is submitted by Prana Biotechnology Limited (not Altery Therapeutics Ltd as indicated in metadata) for the month of April 2004. The registrant is a foreign private issuer based in South Melbourne, Victoria, Australia, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate governance event rather than a financial statement.
Material Changes
The document discloses an Initial Director's Interest Notice (Item 1). No financial material changes or operational updates are detailed in the provided text.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies. It is a procedural filing signed by Geoffrey Kempler, Executive Chairman, on April 2, 2004.
Key Facts for Investor Verification
- Verify the specific details of the Director's Interest Notice referenced in Item 1, as the text only cites the item title without the underlying data.
- Confirm the correct registrant name is Prana Biotechnology Limited, noting the discrepancy with the metadata provided.
- Check subsequent filings for the actual financial performance of the company for the period ending April 2004, as this document contains none.